Page 1 of 1

FDA Regulatory Risk Opinion — Engagement Intake

This intake initiates a confidential, transaction-specific FDA regulatory risk opinion prepared for sponsor-side diligence and investment decision-making.

Requester Qualification

What is your role in this transaction?

What is your role in this transaction?
A
B
C
D
E
F

Firm / Organization Name

Work Email Address

Transaction Context

Transaction Type

Transaction Type
A
B
C
D
E
F

Target Company Name

Estimated Transaction Size

Estimated Transaction Size
A
B
C
D
E

When is this regulatory input required?

When is this regulatory input required?
A
B
C
D

Regulatory Surface Area

Which FDA-regulated areas are relevant to this transaction? (Select all that apply)

Which FDA-regulated areas are relevant to this transaction? (Select all that apply)

Current Regulatory Status of the Target

Current Regulatory Status of the Target
A
B
C
D
Briefly describe any known FDA inspections, Form 483s, warning letters, recalls, or significant compliance events.

Supporting Materials

Upload any available materials relevant to regulatory risk (optional but recommended) - Examples include quality manuals, SOP indices, inspection histories, audit summaries, or existing diligence materials.

Acknowledgements

Scope of Engagement

Scope of Engagement

Confidentiality

Confidentiality

Engagement Acceptance

Engagement Acceptance